Shareholder Structure

Capital Structure

As of November 21, 2022, the company has 14,640,699 issued shares (including 1,291 treasury shares held by SHL, which are dormant shares and have no rights) with a nominal value of NIS 0.01 each (Corresponding to 14,639,327 voting rights)

Ownership Structure

As of  November 21, 2022, SHL was aware of the following shareholders with more than 3% of all voting rights in the company:

Number

Including Treasury Shares

%

Excluding Treasury Shares %

Cai Mengke and Shen Kun

5,969,413

40.77%

40.78%

More Provident Funds

1,318,549

9.01%

9.01%

Value Base Group

837,865

5.72%

5.72%

Yariv Alroy

801,456

5.47%

5.47%

Sphera Funds Management Ltd.596,000

4.07%

4.07%

Danbar Finance Ltd.540,000

3.69%

3.69%

Treasury shares

1,372

0.01%

Public

4,576,044

31.26%

31.26%

Total

14,640,699

100%

100%

The above table of Significant Shareholders reflects both actual holdings as of  November 21, 2022, excluding options and any other purchase positions, after deducting from the total number of shares outstanding 1,372 Ordinary Shares held by SHL, and actual holdings as of  November 21, 2022 calculated including ordinary shares held by SHL, all as indicated above, but does not reflect holdings on a fully diluted basis. All in accordance with notifications received by the Company from its shareholders as of  November 21, 2022.

Disclosure of Management Transactions

SHL Telemedicine has to report to SIX Swiss Exchange all transactions of SHL shares and options made by the Board of Directors and the executive management. The disclosure of management transactions is intended as a means of furthering the supply of information to investors. Such disclosure provides investors with additional qualitative insight with regard to their investment decision.
Click here for the Management Transaction disclosure of SHL Telemedicine on the SIX-Platform.